Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study (vol 83, pg 15, 2023)

被引：3

作者：

Yu, Evan Y. ^{[1
,2
]}

Piulats, Josep M. ^{[3
]}

Gravis, Gwenaelle ^{[4
]}

Fong, Peter C. C. ^{[5
,6
]}

Todenhoefer, Tilman ^{[7
]}

Laguerre, Brigitte ^{[8
]}

Arranz, Jose A. ^{[9
]}

Oudard, Stephane ^{[10
]}

Massard, Christophe ^{[11
,12
]}

Heinzelbecker, Julia ^{[13
,14
]}

Nordquist, Luke T. ^{[15
]}

Carles, Joan ^{[16
]}

Kolinsky, Michael P. ^{[17
,18
]}

Augustin, Marinela ^{[19
]}

Gurney, Howard ^{[20
]}

Tafreshi, Ali ^{[21
]}

Li, Xin Tong ^{[22
]}

Qiu, Ping ^{[22
]}

Poehlein, Christian H. ^{[22
]}

Schloss, Charles

de Bono, Johann S. ^{[23
,24
]}

机构：

[1] Univ Washington, Seattle, WA USA

[2] Fred Hutchinson Canc Ctr, Seattle, WA USA

[3] Catalan Inst Oncol, Barcelona, Spain

[4] Inst Paoli Calmettes, Marseille, France

[5] Auckland City Hosp, Auckland, New Zealand

[6] Univ Auckland, Auckland, New Zealand

[7] Studienpraxis Urol, Nurtingen, Germany

[8] Ctr Eugene Marquis, Rennes, France

[9] Gen Univ Hosp Gregorio Maranon, Madrid, Spain

[10] Univ Paris, Hop Europeen Georges Pompidou, Paris, France

[11] Gustave Roussy, Canc Campus, Villejuif, France

[12] Paris Saclay Univ, Villejuif, France

[13] Saarland Univ, Med Ctr, Homburg, Germany

[14] Saarland Univ, Fac Med, Homburg, Germany

[15] GU Res Network Urol Canc Ctr, Omaha, NE USA

[16] Vall Hebron Inst Oncol, Barcelona, Spain

[17] Cross Canc Inst, Edmonton, AB, Canada

[18] Univ Alberta, Edmonton, AB, Canada

[19] Paracelsus Med Univ, Nurnberg, Germany

[20] Macquarie Univ, Sydney, Australia

[21] Univ Wollongong, Wollongong, NSW, Australia

[22] Merck & Co Inc, Rahway, NJ USA

[23] Inst Canc Res, London, England

[24] Royal Marsden, London, England

来源：

EUROPEAN UROLOGY | 2023年 / 83卷 / 03期

关键词：

D O I：

10.1016/j.eururo.2022.11.025

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E87 / E87

页数：1

共 50 条

[1] Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study
Yu, Evan Y.
Piulats, Josep M.
Gravis, Gwenaelle
Fong, Peter C. C.
Todenhofer, Tilman
Laguerre, Brigitte
Arranz, Jose A.
Oudard, Stephane
Massard, Christophe
Heinzelbecker, Julia
Nordquist, Luke T.
Carles, Joan
Kolinsky, Michael P.
Augustin, Marinela
Gurney, Howard
Tafreshi, Ali
Li, Xin Tong
Qiu, Ping
Poehlein, Christian H.
Schloss, Charles
de Bono, Johann S.
EUROPEAN UROLOGY, 2023, 83 (01) : 15 - 26
[2] Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
Yu, Evan Y.
Kolinsky, Michael P.
Berry, William R.
Retz, Margitta
Mourey, Loic
Piulats, Josep M.
Appleman, Leonard J.
Romano, Emanuela
Gravis, Gwenaelle
Gurney, Howard
Bogemann, Martin
Emmenegger, Urban
Joshua, Anthony M.
Linch, Mark
Sridhar, Srikala
Conter, Henry J.
Laguerre, Brigitte
Massard, Christophe
Li, Xin Tong
Schloss, Charles
Poehlein, Christian H.
de Bono, Johann S.
EUROPEAN UROLOGY, 2022, 82 (01) : 22 - 30
[3] KEYNOTE-365 cohort D: phase 1b/2 study of pembrolizumab plus abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer
Appleman, Leonard
Piulats, Josep
Mar, Nataliya
Arranz, Jose
Joshua, Anthony
Mayer, Tina
Shore, Neal
Wu, Haiyan
Schloss, Charles
Yu, Evan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[4] KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Yu, Evan Y.
Piulats, Josep M.
Gravis, Gwenaelle
Laguerre, Brigitte
Arija, Jose Angel Arranz
Oudard, Stephane
Fong, Peter C. C.
Kolinsky, Michael Paul
Augustin, Marinela
Feyerabend, Susan
Kam, Audrey E.
Gurney, Howard
Tafreshi, Ali
Retz, Margitta
Berry, William R.
Mar, Nataliya
Wu, Helen
Schloss, Charles
Poehlein, Christian Heinrich
De Bono, Johann S.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[5] Pembrolizumab Combination Therapies in Patients With Metastatic Castration-Resistant Prostate Cancer: Cohorts A-C of the Phase 1b/2 KEYNOTE-365 Study
Joshua, Anthony M.
Gurney, Howard
Retz, Margitta
Tafreshi, Ali
Fong, Peter
Shore, Neal
Romano, Emanuela
Augustin, Marinela
Piulats, Josep M.
Berry, William R.
Kolinsky, Michael Paul
Sridhar, Srikala S.
Conter, Henry Joacob
Todenhofer, Tilman
Appleman, Leonard J.
Wu, Haiyan
Schloss, Charles
Poehlein, Christian Heinrich
de Bono, Johann S.
Yu, Evan Y.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 46 - 47
[6] Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study
Yu, Evan Y.
Berry, William R.
Gurney, Howard
Retz, Margitta
Conter, Henry J.
Laguerre, Brigitte
Fong, Peter C. C.
Ferrario, Cristiano
Todenhofer, Tilman
Gravis, Gwenaelle
Piulats, Josep M.
Emmenegger, Urban
Shore, Neal D.
Romano, Emanuela
Mourey, Loic
Li, Xin Tong
Poehlein, Christian H.
Schloss, Charles
Appleman, Leonard J.
Bono, Johann S. de
EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 509 - 518
[7] Phase 1b/2 keynote-365 trial: Pembrolizumab (pembro) combination therapy in metastatic castration-resistant prostate cancer (mCRPC).
Yu, Evan Y.
Wu, Haiyan
Schloss, Charles
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8] Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A update
Arranz Arija, J. A.
Yu, E. Y.
Piulats, J. M.
Gravis, G.
Laguerre, B.
Oudard, S.
Fong, P. C.
Kolinsky, M. P.
Augustin, M.
Todenhofer, T.
Kam, A. E.
Gurney, H.
Tafreshi, A.
Retz, M.
Berry, W. R.
Mar, N.
Wu, H.
Qiu, P.
Schloss, C.
de Bono, J. S.
ANNALS OF ONCOLOGY, 2020, 31 : S513 - S514
[9] PEMBROLIZUMAB PLUS ENZALUTAMIDE IN ABIRATERONE-PRETREATED PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: UPDATED RESULTS FROM KEYNOTE-365 COHORT C
Yu, Evan Y.
Fong, Peter
Piulats, Josep M.
Appleman, Leonard
Conter, Henry
Feyerabend, Susan
Shore, Neal
Gravis, Gwenaelle
Laguerre, Brigitte
Gurney, Howard
Retz, Margitta
Romano, Emanuela
Mourey, Loic
de Bono, Johann S.
Kam, Audrey
Emmenegger, Urban
Wu, Helen
Schloss, Charles
Poehlein, Christian
Berry, William
JOURNAL OF UROLOGY, 2020, 203 : E368 - E368
[10] Phase 1b/2 study of pembrolizumab plus belzutifan and belzutifan alone in patients with docetaxel-treated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort J.
Yu, Evan Y.
Joshua, Anthony M.
Shore, Neal D.
Kramer, Gero
Hu, Haixia
Poehlein, Christian Heinrich
Schloss, Charles
De Bono, Johann S.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : TPS250 - TPS250

← 1 2 3 4 5 →